Abstract:Background: Several reports indicate the high-affinity receptor of NT (neurotensin), NTR1 (neurotensin receptor 1), in numerous detrimental functions linked to neoplastic progression of several cancer types. Recently, it has also been shown that NTR1 gene is a target of the Wnt/APC oncogenic pathways connected with the beta-catenin/Tcf transcriptional complex and NT can stimulate cancer proliferation in an EGFR-dependent mechanism. In this study, we explored NTR1, beta-catenin and EGFR expression in gastric cancer. The possible associations of NTR1 expression with clinicopathological factors, prognosis, beta-catenin and EGFR were analyzed.Methods: NTR1, beta-catenin and EGFR expression in gastric cancer tissues and the adjacent normal tissues of 210 cases was detected by Immunohistochemistry. The possible associations of NTR1 expression with clinicopathological data, prognosis, beta-catenin and EGFR were analyzed.Results: 1. NTR1 expression in tumor tissues was significantly higher than that in adjacent normal tissues (P < 0.01). 2. Its expression was positively correlated with pathological grade, T stage, N stage and TNM stage and was not correlated with sex, age, tumor size and Lauren's classification. 3. A co-expression of NTR1 and nuclear beta-catenin was in 53 (25.2 %) of cases and NTR1 expression was positively correlated with beta-catenin nuclear translocation. NTR1 expression was not correlated with EGFR expression, but at a critical value (P = 0.05). 4. By log-rank test, higher expression of NTR1, higher pathological grade, diffusion Lauren's classification and advanced TNM stage showed worse prognosis (P < 0.05). Age, sex, tumor size, beta-catenin and EGFR had no prognostic significance. Multivariate Cox analysis showed that NTR1 expression and TNM clinical stage (P < 0.05) were the independent prognostic factors for patients with GC.Conclusion: By immunohistochemistry, we found that a high expression of NTR1 in GC specimens, which showed a bad prognosis, besides, NTR1 expression was related to invasion and migration of GC. These findings provide new and important information on the progression of GC. This study indicated that NTR1 may play an important role in tumor progression of GC and have its potential to be a predictive biomarker or a therapeutic molecular target in GC. The interaction between NTR1 and beta-catenin may participate in the development of GC. However, the relationship between NTR1 and EGFR needs to be further investigated.

Upregulation of NPC1 and its association with poor prognosis in gastric cancer

Expression and prognostic significance of Niemann-Pick C1-Like 1 in colorectal cancer: a retrospective cohort study

The role of NPC1L1 in cancer

Prognostic value of multidrug resistance 1, glutathione-S-transferase-pi and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy.

Niemann–Pick C1-like 1 as a Prognostic Marker in Renal Cell Carcinoma: A Retrospective Cohort Study

Upregulation of Caveolin-1 and Cd147 Expression in Nasopharyngeal Carcinoma Enhanced Tumor Cell Migration and Correlated with Poor Prognosis of the Patients

Exploration of NPC2 as a Potential Biomarker for Immunotherapy Using RNA-seq and Protein Data - A New Hypothesis

HYOU1, Regulated by LPLUNC1, is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis

HNRNPC As a Candidate Biomarker for Chemoresistance in Gastric Cancer

Neuropilin-1 Predicts Poor Prognosis and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition in Gastric Cancer

The Significance of Ntr1 Expression and Its Correlation with Beta-Catenin and Egfr in Gastric Cancer

Overexpression of ferroptosis-related gene NFS1 correlates with gastric cancer progression and tumor immune infiltration

Exploring the Diagnostic Value, Prognostic Value, and Biological Functions of NPC Gene Family Members in Hepatocellular Carcinoma Based on a Multi-Omics Analysis.

GPAA1 Promotes Gastric Cancer Progression Via Upregulation of GPI-anchored Protein and Enhancement of ERBB Signalling Pathway

NFS1 as a Candidate Prognostic Biomarker for Gastric Cancer Correlated with Immune Infiltrates

Erratum To: the Significance of NTR1 Expression and Its Correlation with Β-Catenin and EGFR in Gastric Cancer

NPC1 promotes autophagy with tumor promotion and acts as a prognostic model for Hepatocellular Carcinoma

NPC2 as a Prognostic Biomarker for Glioblastoma Based on Integrated Bioinformatics Analysis and Cytological Experiments

hnRNPA1 promotes the metastasis and proliferation of gastric cancer cells through WISP2-guided Wnt/β-catenin signaling pathway

Expression of N-myc Downstream-Regulated Gene 1 in Primary Gallbladder Carcinoma and Its Correlation with Clinicopathological Features and Clinical Outcome.

Nup210 Promotes Colorectal Cancer Progression by Regulating Nuclear Plasma Transport